Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
On October 10, 2022, Philips received the prestigious gold-level Touchstone Award from the Center for Health Design for its innovative Ambient Experience behavioral health rooms at Children's Medical Center Dallas. This solution enhances care for pediatric patients experiencing behavioral health issues by integrating technology to improve staff-patient interactions. The recognition follows multiple other awards for the design, underscoring Philips' commitment to enhancing healthcare delivery through evidence-based design. The solution aims to de-escalate challenging behaviors and improve overall patient experience.
On September 30, 2022, Royal Philips (NYSE: PHG) announced the appointment of Roy Jakobs as the new President and CEO, effective October 15, 2022, succeeding Frans van Houten. The Supervisory Board expressed confidence in Jakobs’ ability to drive the company’s focus on health technology and improve shareholder value. Van Houten reflected on his 12-year tenure and expressed gratitude towards his colleagues. Jakobs emphasized his commitment to innovation and transparency as he prepares to lead Philips into its next chapter.
Philips Sonicare has partnered with actress Marsai Martin as its first Come Back Coach to promote the importance of self-care, particularly through oral hygiene. Martin emphasizes the role of a confident smile in self-esteem and encourages the use of Philips One by Sonicare electric toothbrush. This toothbrush is designed for effective daily routines, featuring a SmarTimer™ and Quadpacer. Priced from $24.99, it is available in various colors. A survey reveals 93% of Americans are seeking self-improvement, with 83% focusing on oral health.
Royal Philips (NYSE: PHG) presented its latest innovations in cardiology at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting held in Boston from September 16-19, 2022. Key highlights include global consensus data advocating the use of intravascular ultrasound (IVUS) for peripheral vascular disease procedures. Philips emphasized the importance of its technology in improving patient outcomes and efficiencies in clinical settings. Notable products showcased include the VeriSight Pro catheter and the EchoNavigator 4.0 imaging system, enhancing diagnostic and therapeutic capabilities in cardiac care.
Philips has announced the upcoming launch of FetView, a cloud-based fetal ultrasound image sharing software designed for obstetrics and gynecology. This vendor-neutral platform will allow physicians to access ultrasound images and patient data in real-time, promoting enhanced diagnostic confidence and better patient communication. FetView aims to streamline workflows, improve departmental efficiency, and reduce costs by enabling secure sharing of medical data. The software will be showcased at the ISUOG World Congress from September 16-18, 2022, in London.
Philips Foundation, RAD-AID International, and Philips have announced a multi-year partnership to enhance access to diagnostic ultrasound services across 10 countries, targeting 50 million people. The initiative will utilize a 'train-the-trainer' model to educate local health workers through real-time distance learning and simulated procedures. This collaboration focuses on improving healthcare in underserved regions by deploying ultrasound devices and providing remote training to address gaps in diagnostic imaging.
Zylorion Health Inc. has announced the appointments of Jeroen Tas to its Board of Directors and Ted Goldstein to its Digital Health Advisory Committee. Tas, former Chief Innovation and Strategy Officer at Philips, and Goldstein, ex-Chief Artificial Intelligence Officer at Elevance Health, bring extensive experience in health technologies and bioinformatics. CEO Peter Silverstone expressed enthusiasm over their addition, highlighting their potential contributions to Zylorion's mission of delivering innovative therapies for mental health challenges, including MDD, TRD, and PTSD.
Philips has achieved significant milestones in developing its Spectral Angio CT suite, integrating breakthrough spectral CT imaging technology for enhanced treatment procedures. Notably, Leiden University Medical Center has joined Philips' clinical network to explore the technology's potential in interventional oncology. Additionally, positive study results were presented at CIRSE 2022, showcasing improved lung tumor biopsy guidance using spectral CT. A collaboration with the University of Pennsylvania aims to enhance tumor treatment effectiveness in real-time.
Royal Philips' subsidiary, Philips Respironics, has issued a voluntary alert regarding certain CPAP and Bi-Level PAP masks with magnetic headgear clips. These masks should not be used by or near individuals with implanted metallic medical devices due to potential magnetic interference. The company has distributed over 17 million such masks and received 14 reports of adverse effects linked to the magnets, including pacemaker failure and seizures. Users are advised to discontinue use and consult a physician for alternatives.
On September 6, 2022, Royal Philips (NYSE: PHG) announced the successful treatment of patients using its innovative VeriSight Pro, a real-time 3D intracardiac echocardiography catheter, at Baptist Health's Miami Cardiac & Vascular Institute. This technology enhances procedural efficiency by reducing the need for sedation, thus improving patient preparation and recovery times. The catheter features superior imaging capabilities and enables interventionalists to navigate cardiac procedures more effectively, ultimately broadening treatment options for patients with structural heart disease.